Symptoms and General Pathology

All Conditions

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Neoplasms

Gland and Hormone Related Diseases

Syndrome

Infertility

Infertility, Female

Polycystic Ovary Syndrome

Genital Diseases

Urogenital Diseases

Genital Diseases, Female

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Cysts

Ovarian Cysts

Ovarian Diseases

Adnexal Diseases

Gonadal Disorders

Endocrine System Diseases

Hypoglycemic Agents

All Drugs and Chemicals

Antineoplastic Agents

Reproductive Control Agents

Metformin

Letrozole

Clomiphene

Enclomiphene

Zuclomiphene

Aromatase Inhibitors

Enzyme Inhibitors

Estrogens

Estrogen Antagonists

Estrogen Receptor Antagonists

Hormones

Hormone Antagonists

5 mg of letrozole will be administered only for 5 days from day 3 each month of spontaneous or induced bleeding plus metformin will be started from the first day with a dose of 850 mg (1 tablet daily) and the dosage will be increased after 1 week up to 1,700 mg/day (2 tablets daily) and will be continued

5 mg of letrozole will be administered only for 5 days from day 3 each month of spontaneous or induced bleeding

letrozole 5 milligram tablets plus metformin 850 milligram tablets

letrozole plus metformin

letrozole

Ahmed Abbas, MD

Polycystic ovary syndrome accounts for the vast majority of anovulatory symptoms and hyperandrogenism in women. The diagnosis of Polycystic ovary syndrome has life-long implications, with increased risk for infertility, metabolic syndrome, and type 2 diabetes mellitus, and possibly for cardiovascular disease and endometrial carcinoma. Polycystic ovary syndrome is diagnosed in adolescents with otherwise unexplained, persistent hyperandrogenic anovulatory symptoms that are inappropriate for age and stage of adolescence. It should be considered in any adolescent girl with a chief complaint of hirsutism, treatment-resistant acne, menstrual irregularity, acanthosis nigricans, and/or obesity

Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome

Efficacy of Combined Letrozole-metformin in Comparison With Letrozole Only in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome

Assiut University

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome	NCT03135301	Infertility, Fe...	letrozole plus ... letrozole	-	Assiut University
Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome	NCT03135301	Infertility, Fe...	letrozole plus ... letrozole	-	Assiut University
Letrozole in Clomiphene Resistant Infertile Women With Polycystic Ovarian Syndrome	NCT03135301	Infertility, Fe...	letrozole plus ... letrozole	-	Assiut University

Spots Global Cancer Trial Database for letrozole plus metformin